{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:26:22Z","timestamp":1780719982558,"version":"3.54.1"},"reference-count":44,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3892\/ol.2015.4031","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T11:44:41Z","timestamp":1450093481000},"page":"1021-1025","source":"Crossref","is-referenced-by-count":47,"title":["Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study"],"prefix":"10.3892","volume":"11","author":[{"given":"SAMEH","family":"HAFSI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SAVERIO","family":"CANDIDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERTA","family":"MAESTRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUCA","family":"FALZONE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZORA","family":"SOUA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BENJAMIN","family":"BONAVIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DEMETRIOS A.","family":"SPANDIDOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASSIMO","family":"LIBRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"key":"key20180108095029_b1-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"key20180108095029_b2-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: T arget recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"key20180108095029_b3-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"key20180108095029_b4-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: Diagnostics monitoring and therapeutics. Histopathology","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol Med"},{"key":"key20180108095029_b5-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"key20180108095029_b6-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: Implications for clinical practice and translational research","volume":"2009","author":"Jaffe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20180108095029_b7-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM198701083160204","article-title":"Multiple recurrent genomic defects in follicular lymphoma. Histopathology","volume":"316","author":"Yunis","year":"1987","journal-title":"N Engl J Med"},{"key":"key20180108095029_b8-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.mayocp.2015.04.025","article-title":"Non-HodgkinL ymphoma: Diagnosis and Treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"key20180108095029_b9-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.seminhematol.2015.01.007","article-title":"Novel targeted therapies in diffuse large B-cell lymphoma","volume":"52","author":"Mehta-Shah","year":"2015","journal-title":"Semin Hematol"},{"key":"key20180108095029_b10-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4049\/jimmunol.175.4.2174","article-title":"Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity, role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively","volume":"175","author":"Vega","year":"2005","journal-title":"J Immunol"},{"key":"key20180108095029_b11-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.onc.1209080","article-title":"Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology","volume":"25","author":"Gordon","year":"2006","journal-title":"Oncogene"},{"key":"key20180108095029_b12-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.4161\/cc.8.9.8314","article-title":"The involvement of the transcription factor Yin Yang 1 in cancer development and progression","volume":"8","author":"Castellano","year":"2009","journal-title":"Cell Cycle"},{"key":"key20180108095029_b13-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1615\/CritRevOncog.v16.i3-4.90","article-title":"Overexpression of Yin Yang 1 in the pathogenesis of human hematopoietic malignancies","volume":"16","author":"Bonavida","year":"2011","journal-title":"Crit Rev Oncog"},{"key":"key20180108095029_b14-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4161\/cc.9.3.10554","article-title":"Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression","volume":"9","author":"Castellano","year":"2010","journal-title":"Cell Cycle"},{"key":"key20180108095029_b15-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2105-10-295","article-title":"Accurate microRNA target prediction correlates with protein repression levels","volume":"10","author":"Maragkakis","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"key20180108095029_b16-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1371\/journal.pbio.0030264","article-title":"Correction: Human MicroRNA targets","volume":"3","author":"John","year":"2005","journal-title":"PLoS Biol"},{"key":"key20180108095029_b17-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat Genet"},{"key":"key20180108095029_b18-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"key20180108095029_b19-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1182\/blood-2010-10-315432","article-title":"Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway","volume":"117","author":"Bueno","year":"2011","journal-title":"Blood"},{"key":"key20180108095029_b20-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/bcj.2012.1","article-title":"MicroRNA signatures in B-cell lymphomas","volume":"2","author":"Di Lisio","year":"2012","journal-title":"Blood Cancer J"},{"key":"key20180108095029_b21-ol-0-0-4031","first-page":"557","article-title":"MicroRNAs in diffuse large B-cell lymphoma, implications for pathogenesis, diagnosis, prognosis and therapy","volume":"34","author":"Troppan","year":"2014","journal-title":"Anticancer Res"},{"key":"key20180108095029_b22-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-cell lymphomas: How a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"key":"key20180108095029_b23-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.2174\/1381612820666140128211346","article-title":"MicroRNAs as anti-cancer therapy","volume":"20","author":"Garofalo","year":"2014","journal-title":"Curr Pharm Des"},{"key":"key20180108095029_b24-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-014-0568-y","article-title":"Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients","volume":"16","author":"Lim","year":"2015","journal-title":"Genome Biol"},{"key":"key20180108095029_b25-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0092-8674(91)90189-6","article-title":"Transcriptional repression by YY1, a human GLI-Kr\u00fcppel-related protein, and relief of repression by adenovirus E1A protein","volume":"67","author":"Shi","year":"1991","journal-title":"Cell"},{"key":"key20180108095029_b26-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1038\/sj.onc.1201843","article-title":"Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells","volume":"16","author":"Lee","year":"1998","journal-title":"Oncogene"},{"key":"key20180108095029_b27-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/carcin\/bgm092","article-title":"WuL ee YH and Yeh TS: The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1","volume":"28","author":"Liao","year":"2007","journal-title":"Carcinogenesis"},{"key":"key20180108095029_b28-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/bcr1851","article-title":"The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors","volume":"10","author":"Allouche","year":"2008","journal-title":"Breast Cancer Res"},{"key":"key20180108095029_b29-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"24428","DOI":"10.1074\/jbc.M503790200","article-title":"Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells","volume":"280","author":"Begon","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180108095029_b30-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajpath.2012.01.037","article-title":"Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27","volume":"180","author":"Wan","year":"2012","journal-title":"Am J Pathol"},{"key":"key20180108095029_b31-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular senescence and tumor suppressor gene p16","volume":"130","author":"Rayess","year":"2012","journal-title":"Int J Cancer"},{"key":"key20180108095029_b32-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/nass\/nrm174","article-title":"Cooperative regulation og p73 promoter by Yin Yang 1 and E2F1","volume":"51","author":"Wu","year":"2007","journal-title":"Nucleic Acids Symp Ser (Oxf)"},{"key":"key20180108095029_b33-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0402283101","article-title":"YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress","volume":"101","author":"Gr\u00f6nroos","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108095029_b34-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"12520","DOI":"10.1073\/pnas.92.26.12520","article-title":"Frequent somatic hypermutation of the 5\u2032 noncoding region of the BCL6 gene in B-cell lymphoma","volume":"92","author":"Migliazza","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108095029_b35-ol-0-0-4031","first-page":"115","article-title":"Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia","volume":"1","author":"Libra","year":"2010","journal-title":"Immunopathol Dis Therap"},{"key":"key20180108095029_b36-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2004.06.004","article-title":"Yin Yang 1 is a negative regulator of p53","volume":"117","author":"Sui","year":"2004","journal-title":"Cell"},{"key":"key20180108095029_b37-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1128\/MCB.26.9.3565-3581.2006","article-title":"Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression","volume":"26","author":"Affar","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20180108095029_b38-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V89.7.2523","article-title":"Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21","volume":"89","author":"Maestro","year":"1997","journal-title":"Blood"},{"key":"key20180108095029_b39-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/bgq033","article-title":"Epigenetic inactivation of the miR-34a in hematological malignancies","volume":"31","author":"Chim","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20180108095029_b40-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2008.207","article-title":"Involvement of p53 and Raf\/MEK\/ERK pathways in hematopoietic drug resistance","volume":"22","author":"McCubrey","year":"2008","journal-title":"Leukemia"},{"key":"key20180108095029_b41-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00428-012-1309-9","article-title":"Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression","volume":"461","author":"van Kempen","year":"2012","journal-title":"Virchows Arch"},{"key":"key20180108095029_b42-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00417-011-1885-4","article-title":"MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2","volume":"250","author":"Cai","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key20180108095029_b43-ol-0-0-4031","doi-asserted-by":"crossref","first-page":"347137","DOI":"10.1155\/2011\/347137","article-title":"Micro-RNA expression and function in lymphomas","volume":"2011","author":"Sandhu","year":"2011","journal-title":"Adv Hematol"},{"key":"key20180108095029_b44-ol-0-0-4031","first-page":"6847","article-title":"Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer","volume":"8","author":"Zou","year":"2015","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.4031\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T16:45:04Z","timestamp":1599929104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.4031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,14]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,12,14]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.3892\/ol.2015.4031"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.4031","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,14]]}}}